Palatin Technologies Inc. (PTN)

[mikedeatworld]

Conference Call Transcript that is interesting:

From a past Palatin Conference Call I was just reading through ---

I think the main question is really the regulatory uncertainty, and that has been changing. And so I think as the regulatory uncertainty hopefully gets clarified coming out of the June 4 meeting, and then I guess, a little later in the year, should the panel recommend approval, hopefully that drug getting approved, I think that really helps to remove one of the remaining obstacles that we see to finalizing a substantial transaction for bremelanotide.
There are only two of us in the marketplace, I mean there is flibanserin and there's bremelanotide, so there are lot of companies that sell into the OB/GYN space, so if one gets one, somebody is going to need another one. So I think we'd be well-positioned.

CEO Carl Spana Palatin

Should we be bullish on a buyout?
http://seekingalpha.com/article/3180556-palatin-technologies-ptn-ceo-carl-spana-on-q3-2015-results-earnings-call-transcript?page=4&p=qanda&l=last